Nrx Pharmaceuticals Inc (NRXP)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Nrx Pharmaceuticals Inc-Aktie (NRXP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-03-31	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate
Revenues	-	-	-
Income/Loss From Continuing Operations Before Tax	30.20% -5.512	-7.897	-6.528
Income Tax Expense/Benefit	-	-	-
Income/Loss From Continuing Operations After Tax	30.20% -5.512	-7.897	-6.528
Net Income/Loss	30.20% -5.512	-7.897	-6.528
Preferred Stock Dividends And Other Adjustments	-	-	-
Attributable To Noncontrolling Interest	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-

RVMD

$102.71

28.63%

GMAB

$33.90

2.42%

INCY

$110.57

3.67%

BNTX

$100.08

2.03%

ONC

$333.87

4.22%

INSM

$176.00

0.53%